title: Relapsing multiple sclerosis patients can look to second oral agent.
authors: National Association of Managed Care Physicians, USA. TMorrow@ManagedCareMag.com
authors: Thomas
authors: T
authors: Morrow
mesh_terms: D003437:Crotonates / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D006885:Hydroxybutyrates; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D009570:Nitriles; D016032:Randomized Controlled Trials as Topic; D014052:Toluidines / Q000627:therapeutic use*; D014481:United States
chemical_list: D003437:Crotonates; D006885:Hydroxybutyrates; D009570:Nitriles; D014052:Toluidines; C527525:teriflunomide